Oncogenes and cell death
- 28 February 1994
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 4 (1), 120-129
- https://doi.org/10.1016/0959-437x(94)90100-7
Abstract
Several recent studies have implicated oncogenes and tumour suppressor genes in the regulation of programmed cell death (apoptosis). Lesions in the cell death pathway appear to be important in both carcinogenesis and the evolution of drug resistance in tumours. They include deregulated expression of genes such as bcl-2, loss of p53, and autocrine activation of anti-apoptotic signal transduction pathways. Paradoxically, a number of dominant oncogenes appear to act as potent inducers of apoptosis. This suggests that the pathways of cell proliferation and cell death may be tightly coupled, an idea that may have dramatic implications for models of oncogene co-operation and carcinogenesis.Keywords
This publication has 85 references indexed in Scilit:
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The bcl-2 Protein Is Inserted into the Outer Membrane but Not into the Inner Membrane of Rat Liver Mitochondria in VitroBiochemical and Biophysical Research Communications, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Retinoblastoma protein and the cell cycleCurrent Opinion in Genetics & Development, 1993
- The retinoblastoma protein and the regulation of cell cyclingTrends in Biochemical Sciences, 1992
- p53, guardian of the genomeNature, 1992
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell deathDevelopmental Biology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- c-myc Oncogene expression inhibits the initiation of myogenic differentiationExperimental Cell Research, 1987